Invictus RG’s Orthofix Medical OFIX Stock Holding History

Invictus RG’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,234	Closed	-$342K	–	422
2017 Q3	$342K	Buy	+7,234	New	+$341K	0.31%	132

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Invictus RG's OFIX Position: Q4 2017 in Review

Invictus RG sold out of Orthofix Medical (OFIX) in Q4 2017, closing a stake of 7,234 shares — an estimated $342K sold.

Invictus RG first reported a position in OFIX in Q3 2017 and held it in 1 quarter. The position peaked at $342K in Q3 2017. 164 funds tracked by Wall St. Rank hold OFIX as of Q4 2017.

Invictus RG reported no remaining Orthofix Medical position as of Q4 2017 after selling out during the quarter.
Invictus RG sold 7,234 Orthofix Medical shares in Q4 2017, an estimated $342K.
Invictus RG first reported a position in Orthofix Medical in Q3 2017 and held it in 1 quarter.
Invictus RG's Orthofix Medical position peaked at $342K in Q3 2017.
164 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2017.

Based on Invictus RG's 13F filing for Q4 2017, filed 13 Feb 2018.